Sales Reps Hit Daiichi Sankyo With FLSA Action
The U.S. subsidiary of international drug company Daiichi Sankyo Co. Ltd. has been hit with a putative collective action claiming it wrongly exempts pharmaceutical sales representatives from the overtime compensation requirements...To view the full article, register now.
Already a subscriber? Click here to view full article